Insights & Events Uncommon Knowledge
Feature
FinCEN Issues Interim CTA Rule, U.S. Entities and Individuals Exempted From Reporting
Federal Circuit Confirms Calculation of PTE for Reissue Patents Under Regulatory Review
HHS-OIG Highlights Anti-Fraud Safeguards of Drug Manufacturer’s Free Drug Program for Patients in Financial Need
Supreme Court of New Jersey Clarifies Fault Allocation for Non-Parties Outside of the Court’s Jurisdiction
Executive Order Signals Healthcare Price Transparency as a Priority
Seventh Circuit Roundup: New Decisions on Section 1983 and Qualified Immunity (Plus: Who Decides When Litigation Conduct Waives Arbitration?)
UNCOMMON UNDERSTANDING OF BUSINESS ISSUES
KEEP IN TOUCH
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you're interested in learning more about.
Visit Subscription Center
